|
Background: Bronchopulmonary dysplasia (BPD), a
chronic lung disease primarily observed in premature
infants, is attributed to a lung injury–repair imbalance.
Studies of postnatal corticosteroids have failed to identify
clear candidates to help alleviate high BPD rates without
risks or adverse effects.
Purpose: This study aimed to assess whether the systemic
postnatal administration of an alternative glucocorticoid,
ciclesonide, could attenuate alterations in lung
structure and right ventricular hypertrophy in a... |